Therapeutic Advancements in Myelodysplastic Syndromes: Essential Guidance for Nursing Practice

Therapeutic Advancements in Myelodysplastic Syndromes: Essential Guidance for Nursing Practice

Chair, Sara M. Tinsley, PhD, APRN, AOCN, Sandra Kurtin, PhD, ANP-C, AOCN, and David Sallman, MD, discuss myelodysplastic syndromes in this CME/MOC/NCPD/ILNA activity titled “Therapeutic Advancements in Myelodysplastic Syndromes: Bridging the Gap Between Patient Safety and Quality Care Through the Latest Science and Evidence-Based Learning in Nursing Practice.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/EQN865. CME/MOC/NCPD/ILNA credit will be available until May 6, 2022.

• Kategorija